Lack of pharmacokinetic interaction between cefepime and amikacin in humans.
The interaction potential between cefepime and amikacin was investigated in a steady-state pharmacokinetic study in 16 healthy male subjects. Eight subjects (group A) received a first course of 2,000 mg of cefepime; this was followed by a second course of 2,000 mg of cefepime with 300 mg of amikacin...
Sparad:
| I publikationen: | Antimicrob Agents Chemother |
|---|---|
| Huvudupphov: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
1992
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191590/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1510431/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.7.1382 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|